Literature DB >> 21465478

The tumor suppressor role of CTCF.

Francesco Paolo Fiorentino1, Antonio Giordano.   

Abstract

CTCF is an evolutionary conserved and ubiquitously expressed protein that binds thousands of sites in the human genome. Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor. In this review article, we focused on the molecular mechanisms engaged by CTCF to modulate the expression of several key-regulators of differentiation, cellular senescence, cell cycle control and progression, whose expression is frequently altered in tumors. Moreover, we discussed common features of CTCF at each tumor-related DNA-binding sequence, such as protein-partners, post-translational modifications, and distinctive epigenetic marks establishment. The investigation of the molecular mechanisms engaged by CTCF to modulate tumor-related genes emphasizes the cell-type dependency of its tumor suppressor role. Indeed, the ability of CTCF to bind their promoters strictly depends by cell-type features as DNA methylation, BORIS-binding and post-translational modifications as PARYlation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21465478     DOI: 10.1002/jcp.22780

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

1.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

3.  CTCF mediates effect of insulin on glucagon expression.

Authors:  Shanli Tsui; Jie Gao; Charles Wang; Luo Lu
Journal:  Exp Cell Res       Date:  2012-03-08       Impact factor: 3.905

4.  The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.

Authors:  Da Wang; Changlong Li; Xuemei Zhang
Journal:  DNA Cell Biol       Date:  2014-05-19       Impact factor: 3.311

5.  P50-associated COX-2 extragenic RNA (PACER) overexpression promotes proliferation and metastasis of osteosarcoma cells by activating COX-2 gene.

Authors:  Ming Qian; Xinghai Yang; Zhenxi Li; Cong Jiang; Dianwen Song; Wangjun Yan; Tielong Liu; Zhipeng Wu; Jinhai Kong; Haifeng Wei; Jianru Xiao
Journal:  Tumour Biol       Date:  2015-10-17

6.  CCCTC-binding factor mediates effects of glucose on beta cell survival.

Authors:  S Tsui; W Dai; L Lu
Journal:  Cell Prolif       Date:  2013-12-20       Impact factor: 6.831

7.  TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Authors:  Jian Chen; Zhi-Xing Yao; Jiun-Sheng Chen; Young Jin Gi; Nina M Muñoz; Suchin Kundra; H Franklin Herlong; Yun Seong Jeong; Alexei Goltsov; Kazufumi Ohshiro; Nipun A Mistry; Jianping Zhang; Xiaoping Su; Sanaa Choufani; Abhisek Mitra; Shulin Li; Bibhuti Mishra; Jon White; Asif Rashid; Alan Yaoqi Wang; Milind Javle; Marta Davila; Peter Michaely; Rosanna Weksberg; Wayne L Hofstetter; Milton J Finegold; Jerry W Shay; Keigo Machida; Hidekazu Tsukamoto; Lopa Mishra
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

8.  A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.

Authors:  Claudia Fabiola Méndez-Catalá; Svetlana Gretton; Alexander Vostrov; Elena Pugacheva; Dawn Farrar; Yoko Ito; France Docquier; Georgia-Xanthi Kita; Adele Murrell; Victor Lobanenkov; Elena Klenova
Journal:  Neoplasia       Date:  2013-08       Impact factor: 5.715

9.  Multilayered chromatin analysis reveals E2f, Smad and Zfx as transcriptional regulators of histones.

Authors:  David Gokhman; Ilana Livyatan; Badi Sri Sailaja; Shai Melcer; Eran Meshorer
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.